Every year millions of the world’s poorest people die from curable or preventable infectious diseases or suffer unnecessary ill health because they do not have access to basic health care services, including essential medicines and vaccines. The reasons for this are complex and plentiful....but these problems cannot be an excuse for inaction, writes Andrew Witty, CEO of GlaxoSmithKline.
The threat is no longer low-cost manufacturing; it’s high-tech and ideas. And the proof? As of this year, China has overtaken Germany as the world’s biggest exporter. And it’s not limited to less expensive products.
I have always advocated for investment in engineering – to both improve society and stimulate economies. It’s true that as engineer myself I have a vested interest. But following the financial fallout this is no longer just a point of view. It’s a necessity, writes Sir James Dyson.
One major bank's recent announcement that it will boost base pay while reducing bonus opportunities for certain employees spawned headlines around the globe, and with good reason.
CNBC viewers share their memories of CNBC Chief Commentator Bill Seidman.
CNBC Anchor Bill Griffeth shares memories of Bill Seidman that reflect on the special character of the former FDIC chairman and CNBC chief commentator.
Under the new "bailout" — "rescue" — legislation, Treasury will be purchasing billions of dollars of mortgage-backed securities — mostly backed by subprime mortgages.
The Fed is expected to end its quantitative easing program—the much-anticipated action that's been at the very heart of the market's fears.
Pro investor Ralph Acampora sees no reason for the rally to end. “October was its obnoxious self,” he said.
Crude oil continues to flirt with the key $80 per barrel level, signaling another possible sharp leg down in price in the coming weeks.
Stocks rose Friday, adding to weekly gains.